AMERICAN SHARED HOSPITAL SERVICES AMS
AMEX Price as of Nov 13, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Jun 30, 2026
Market cap
$7.25M
P/E (GAAP, TTM)
—
P/E (operating)
—
Dividend yield
0.0%
Revenue growth YoY
19.2%
EPS growth YoY
-75.0%
ROIC
-7.5%
Piotroski F-score
5
Three ways to read the P/E
P/E (GAAP, TTM)
—
Net income of the last 4 quarters. Includes investment gains and one-time items.
P/E (GAAP, annual)
—
Net income of the latest fiscal year. Includes investment gains and one-time items.
P/E (operating)
—
After-tax operating income only: the core business.
P/E (excl. gains)
—
Net income after removing identified investment and asset-sale gains.
How it has changed
Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.
| Metric | 2026Q3 | 2026Q2 | Change QoQ | 2025Q3 | Change YoY |
|---|---|---|---|---|---|
| Revenue growth YoY (qtr) | 19.2% | 15.9% | +3.3 pts | 0.2% | +19.0 pts |
| EPS growth YoY (qtr) | -75.0% | 10.0% | -85.0 pts | -107.3% | +32.3 pts |
| Revenue growth (TTM) | 4.0% | -0.6% | +4.6 pts | 26.6% | -22.6 pts |
| EPS growth (TTM) | 34.2% | -204.8% | +239.0 pts | -157.6% | +191.8 pts |
| P/E (GAAP, TTM) | — | — | — | — | — |
| P/E (operating) | — | — | — | — | — |
| P/E (excl. gains) | — | — | — | — | — |
| P/B | 0.39 | 0.43 | -0.04 | — | — |
| ROIC | -7.5% | -7.5% | 0.0 pts | -8.2% | +0.7 pts |
| Net margin | -5.5% | -5.5% | 0.0 pts | 7.7% | -13.2 pts |
| Dividend yield | 0.0% | 0.0% | 0.0 pts | — | — |
| EPS (TTM) | -0.25 | -0.22 | -13.6% | -0.38 | +34.2% |
| Price | $1.42 | $1.57 | -9.6% | — | — |
History by quarter-end
Reported quarters
| Quarter ended | Revenue | QoQ | YoY | EPS | QoQ | YoY | Net margin |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | $8.43M | 19.0% | 19.2% | -0.07 | 22.2% | -75.0% | -6.1% |
| Mar 31, 2026 | $7.08M | -8.3% | 15.9% | -0.09 | 0.0% | 10.0% | -8.6% |
| Dec 31, 2025 * | $7.73M | 7.8% | -14.8% | -0.09 | — | 57.1% | -8.2% |
| Sep 30, 2025 | $7.17M | 1.4% | 2.5% | 0.00 | 100.0% | 100.0% | -0.2% |
| Jun 30, 2025 | $7.07M | 15.7% | 0.2% | -0.04 | 60.0% | -107.3% | -4.0% |
| Mar 31, 2025 | $6.11M | -32.6% | 17.2% | -0.10 | 52.4% | -600.0% | -10.2% |
| Dec 31, 2024 * | $9.07M | 29.6% | 59.2% | -0.21 | -600.0% | -400.0% | -14.6% |
| Sep 30, 2024 | $7.00M | -0.8% | 36.3% | -0.03 | -105.5% | -250.0% | -3.0% |
| Jun 30, 2024 | $7.06M | 35.3% | 26.7% | 0.55 | 2,650.0% | 2,850.0% | 51.0% |
| Mar 31, 2024 | $5.22M | -8.5% | 5.9% | 0.02 | -71.4% | -33.3% | 2.3% |
| Dec 31, 2023 * | $5.70M | 11.0% | 13.1% | 0.07 | 250.0% | 75.0% | 7.3% |
| Sep 30, 2023 | $5.13M | -7.8% | 6.3% | 0.02 | 200.0% | -60.0% | 2.3% |
* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.
All figures
Price & size
| Fiscal year end | Dec 31, 2025 | End date of the latest annual (10-K) report used. |
|---|---|---|
| Price date | Nov 13, 2026 | Date of the latest closing price used. |
| Price | $1.09 | Latest closing price. |
| Market cap | $7.25M | Price × shares outstanding. |
| Enterprise value | $21.08M | Market cap + debt − cash: the price of the whole business. |
| Shares | 6.65M | Shares outstanding used for market cap. |
Valuation
| P/E (GAAP, annual) | — | Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative. |
|---|---|---|
| P/E (GAAP, TTM) | — | Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items. |
| P/E (operating) | — | Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items. |
| P/E (operating, TTM) | — | Market cap ÷ after-tax operating income of the last four quarters. |
| P/E (excl. gains) | — | Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified. |
| PEG | — | P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap. |
| PEG (TTM) | — | TTM P/E ÷ TTM EPS growth rate (in %). |
| Earnings yield | -21.4% | Net income ÷ market cap. The inverse of the P/E. |
| Earnings yield (TTM) | -22.9% | TTM EPS ÷ price. |
| P/B | 0.30 | Market cap ÷ shareholders' equity. Blank when equity is negative. |
| P/S | 0.26 | Market cap ÷ revenue of the latest fiscal year. |
| P/S (TTM) | 0.24 | Market cap ÷ revenue of the last four quarters. |
| P/FCF | — | Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative. |
| EV/EBITDA | 9.92 | Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels. |
| EV/EBIT | — | Enterprise value ÷ operating income. |
| EV/Sales | 0.75 | Enterprise value ÷ revenue. |
| Book value / share | 3.61 | Shareholders' equity ÷ shares. |
| FCF yield | -62.6% | Free cash flow ÷ market cap. |
Operating vs. one-time earnings
| Operating EPS | -0.43 | After-tax operating income per share (latest fiscal year). |
|---|---|---|
| Investment gains | — | Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified. |
| Asset-sale gains | $0 | One-time gains or losses from selling property, assets or businesses. Blank = none identified. |
| Non-operating income | $368.00K | Pre-tax income minus operating income: interest, investment results and one-time items combined. |
| Gains as % of net income | 0.0% | Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains. |
Latest quarter & trailing 12 months
| Latest quarter | Jun 30, 2026 | End date of the most recent reported quarter. |
|---|---|---|
| Revenue (qtr) | $8.43M | Revenue of the latest reported quarter. |
| Net income (qtr) | -$514.00K | Net income of the latest reported quarter. |
| EPS (qtr) | -0.07 | Diluted EPS of the latest reported quarter. |
| Revenue growth YoY (qtr) | 19.2% | Latest quarter revenue vs the same quarter a year earlier. |
| Revenue growth QoQ (qtr) | 19.0% | Latest quarter revenue vs the previous quarter. |
| EPS growth YoY (qtr) | -75.0% | Latest quarter EPS vs the same quarter a year earlier. |
| EPS growth QoQ (qtr) | 22.2% | Latest quarter EPS vs the previous quarter. |
| Net income growth YoY (qtr) | -83.6% | Latest quarter net income vs the same quarter a year earlier. |
| Net income growth QoQ (qtr) | 16.0% | Latest quarter net income vs the previous quarter. |
| Gross margin (qtr) | 17.0% | Gross profit ÷ revenue in the latest quarter. |
| Operating margin (qtr) | -10.8% | Operating income ÷ revenue in the latest quarter. |
| Net margin (qtr) | -6.1% | Net income ÷ revenue in the latest quarter. |
| Revenue (TTM) | $30.41M | Revenue of the last four quarters. |
| Net income (TTM) | -$1.77M | Net income of the last four quarters. |
| EPS (TTM) | -0.25 | Sum of the last four quarters of diluted EPS. |
| Revenue growth (TTM) | 4.0% | Last four quarters of revenue vs the four quarters before. |
| EPS growth (TTM) | 34.2% | Last four quarters of EPS vs the four quarters before. |
| Net income growth (TTM) | 27.3% | Last four quarters of net income vs the four quarters before. |
Dividends & shareholder returns
| Dividend yield | 0.0% | Dividends paid per share over the last 12 months ÷ price. |
|---|---|---|
| Dividend / share (TTM) | — | Dividends per share paid over the last 12 months. |
| Payout ratio | — | Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings. |
| FCF payout ratio | — | Dividends ÷ free cash flow. |
| Dividend growth (1y) | — | Dividends per share vs the same 12-month window a year earlier. |
| Dividend CAGR (3y) | — | Annualised dividend growth over 3 years. |
| Dividend CAGR (5y) | — | Annualised dividend growth over 5 years. |
| Payments (12m) | — | Number of dividend payments in the last 12 months. |
| Last ex-dividend date | — | Most recent ex-dividend date. |
| Buyback yield | 0.0% | Share repurchases ÷ market cap. |
| Shareholder yield | 0.0% | Dividend yield + buyback yield. |
Profitability
| Gross margin | 18.0% | Gross profit ÷ revenue (latest fiscal year). |
|---|---|---|
| EBITDA margin | 7.6% | EBITDA ÷ revenue. |
| Operating margin | -12.8% | Operating income ÷ revenue. |
| Net margin | -5.5% | Net income ÷ revenue. |
| FCF margin | -16.2% | Free cash flow ÷ revenue. |
| ROE | -6.5% | Return on equity: net income ÷ shareholders' equity. Blank when equity is negative. |
| ROA | -2.8% | Return on assets: net income ÷ total assets. |
| ROIC | -7.5% | Return on invested capital: after-tax operating income ÷ (equity + debt − cash). |
Growth (annual)
| Revenue growth (annual) | -0.9% | Latest fiscal year revenue vs the year before. |
|---|---|---|
| Net income growth (annual) | -171.0% | Latest fiscal year net income vs the year before. |
| EPS growth (annual) | -169.7% | Latest fiscal year diluted EPS vs the year before. |
| Revenue CAGR (3y) | 12.5% | Annualised revenue growth over 3 fiscal years. |
| EPS CAGR (3y) | — | Annualised EPS growth over 3 fiscal years. |
Financial health
| Current ratio | 0.76 | Current assets ÷ current liabilities. Above 1 means short-term bills are covered. |
|---|---|---|
| Quick ratio | 0.76 | (Current assets − inventory) ÷ current liabilities. |
| Cash ratio | 0.15 | Cash ÷ current liabilities. |
| Debt / equity | 0.72 | Total debt ÷ shareholders' equity. Blank when equity is negative. |
| Debt / assets | 0.31 | Total debt ÷ total assets. |
| Debt / EBITDA | 8.13 | Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt. |
| Net debt / EBITDA | 6.51 | (Debt − cash) ÷ EBITDA. Negative means more cash than debt. |
| Interest coverage | -2.28 | Operating income ÷ interest expense. |
Earnings quality
| FCF conversion | — | Free cash flow ÷ net income. Above 100% means profits turn into real cash. |
|---|---|---|
| Accruals ratio | -8.4% | (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings. |
| Stock comp % revenue | 1.4% | Share-based compensation ÷ revenue. |
| R&D % revenue | — | Research & development spending ÷ revenue. |
| SG&A % revenue | 25.2% | Selling, general & administrative expense ÷ revenue. |
| Tax rate used | 21.0% | Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown). |
Efficiency
| Asset turnover | 0.51 | Revenue ÷ total assets. |
|---|---|---|
| Days sales outstanding | 137 | Average days to collect payment from customers. |
| Days inventory | — | Average days inventory is held. |
| Days payables | 10 | Average days to pay suppliers. |
Trading & momentum
| 52-week high | $2.39 | Highest price in the last 52 weeks. |
|---|---|---|
| 52-week low | $0.9800 | Lowest price in the last 52 weeks. |
| From 52-week high | -54.4% | How far below the 52-week high the price is (0% = at the high). |
| Above 52-week low | 11.2% | How far above the 52-week low the price is. |
| Avg volume (30d) | 9.71K | Average shares traded per day over the last 30 days. |
| Avg $ volume (30d) | $11.68K | Average dollars traded per day over the last 30 days: a liquidity measure. |
Scores
| Piotroski F-score | 5 | Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail. |
|---|---|---|
| Altman Z-score | 0.43 | Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers. |
Reported figures (latest fiscal year)
| Revenue | $28.08M | Revenue of the latest fiscal year. |
|---|---|---|
| Net income | -$1.55M | Net income of the latest fiscal year. |
| Diluted EPS | -0.23 | Diluted earnings per share of the latest fiscal year. |
| EBITDA | $2.13M | Operating income + depreciation & amortization. |
| Free cash flow | -$4.54M | Operating cash flow − capital spending. |
| Total debt | $17.29M | Long-term plus current debt. |
| Cash | $3.46M | Cash and equivalents. |
| Equity | $24.03M | Shareholders' equity. |
| Total assets | $55.48M | Total assets. |